Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT02817607

Study to Assess Breast Sensation Before and After Breast Cancer Treatment

Pilot Study to Assess Breast Sensation Before and After Breast Cancer Treatment

Status
Withdrawn
Phase
N/A
Study type
Interventional
Enrollment
0 (actual)
Sponsor
Duke University · Academic / Other
Sex
All
Age
25 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to establish techniques for evaluating breast cutaneous sensation at baseline and following either lumpectomy or mastectomy for breast cancer.

Detailed description

Measuring nerve recovery and breast sensibility has been reported in a limited fashion in the past. A number of studies have assessed patients before and after breast reduction surgery using Semmes-Weinstein monofilaments and found this to be an effective technique. A limited number of studies have been done in patients undergoing mastectomy for breast cancer using these techniques. The main limitation of these existing studies is the lack of prospective measurements before surgery and through time, thus restricting the findings to isolated long-term outcomes. Additionally, no studies have compared patients undergoing mastectomy versus lumpectomy to determine the impact that surgical approach has on breast sensibility.

Conditions

Interventions

TypeNameDescription
PROCEDURESensory testing and BiopsySemmes-Weinstein testing: Each breast will be subdivided into 5 regions. This will include the upper 1/3rd, the middle 1/3rd medial and lateral to the nipple areola complex, the lower 1/3rd and the nipple areola-complex. These regions are consistent with the dermatomes described for the breast innervation. A cutaneous nerve/skin biopsy is a simple procedure commonly performed on an outpatient setting. The total procedure is expected to take 20 minutes and may be done at the time of surgery as well as 2 and 6 months post operatively either during a revision or at a follow up visit.

Timeline

Start date
2016-12-01
Primary completion
2018-08-01
Completion
2018-08-01
First posted
2016-06-29
Last updated
2019-05-07

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02817607. Inclusion in this directory is not an endorsement.